Irinotecan or Fluorouracil Plus Leucovorin in Treating Patients With Previously Treated Metastatic Colorectal Cancer
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Giving the drugs in different combinations may kill more tumor
cells.
PURPOSE: Phase II trial to compare the effectiveness of either irinotecan or fluorouracil
plus leucovorin in treating patients who have metastatic colorectal cancer that has been
previously treated with oxaliplatin with or without irinotecan.